Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease (3xTg-AD): hippocampus - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4413

Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease (3xTg-AD): hippocampus

Analysis of hippocampus from 10 month-old, triple-transgenic AD females treated with the thiazolidinedione pioglitazone (PIO) for 14 weeks. TZDs exert cognitive benefits early in the AD process. Results provide insight into molecular mechanisms underlying the neuroprotective role of PIO in AD.

Organism:: Mus musculus

Type:: Expression profiling by array, transformed count, 2 agent sets

Platform:: GPL1261
Series:: GSE32536
16 Samples

Download data: CEL

DataSet

Accession:: GDS4413

ID:: 4413

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease ...
Long-term pioglitazone effect on triple transgenic model of Alzheimer's disease (3xTg-AD): hippocampus
Accession: GDS4413

GEO DataSets
Related DataSets for GEO Profiles (Select 89265943) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets